The largest database of trusted experimental protocols

Pgipz lentiviral vector

Manufactured by Horizon Discovery
Sourced in United States

The PGIPZ lentiviral vector is a tool used for gene knockdown and expression studies. It contains a green fluorescent protein (GFP) reporter and a puromycin resistance gene for selection of transduced cells. The vector is designed for the introduction and stable expression of short hairpin RNA (shRNA) sequences, which can be used to silence target genes.

Automatically generated - may contain errors

6 protocols using pgipz lentiviral vector

1

RARRES1 shRNA Knockdown and 5-aza-2'-deoxycitidine Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines were obtained from the American Type Culture Collection (ATCC) and cultured as described in Supplementary Table 1. RARRES1 shRNA knockdown clones were generated as previously described [15 (link),45 ], using the pGipZ lentiviral vector (shRNA 1: V3LHS_398249; shRNA 2: V3LHS_398251; Dharmacon). Western blotting was used to verify RARRES1 expression (R&D anti-RARRES1, cat#AF4255, 1/300).
For 5-aza-2′-deoxycitidine (DAC) treatment, 1 μM DAC (Sigma) was added for 72 hours and replaced every 24 h. When used in combination with all-trans retinoic acid (RA), 100 nM RA (Sigma) was added for the last 18 h.
+ Open protocol
+ Expand
2

Downregulating AnxA6 in Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small-hairpin RNAs (shRNAs) targeting the coding sequence of AnxA6 (A6sh) in pGIPZ lentiviral vector, a non-silencing shRNA control (26 (link)) (GE Dharmacon), were used to prepare lentiviral stocks in 293 T cells, and the viral particles were used to infect LAP-R (P3) breast cancer cells as described previously (25 (link)). The resulting subclones of LAP-R cells were denoted LAP-R-NSC, LAP-R-A6sh5 and LAP-R-A6sh2. Downregulation of AnxA6 was verified by immunoblotting.
+ Open protocol
+ Expand
3

Generating Stable Reporter Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the transient reporter analyses, PD-L1 and PD-L2 promoters were amplified by PCR from genomic DNA obtained from Jurkat cells using the primers listed in Table S1 and cloned into the multicloning site (MCS) of the PGL3 Basic Vector (Promega Corporation) as previously described (Sambrook et al., 1989 ; full methods can be found in Supplemental Experimental Procedures). Specific deletions of the putative binding sites were carried out using the Q5 Site-Directed Mutagenesis Kit (New England Biolabs), with primers and templates listed in Table S1. Normalization pRL-SV40P plasmid (Addgene plasmid 27163) was a gift from Ron Prywes (Chen and Prywes, 1999 (link)), who deposited the plasmid at the Addgene public repository.
For the stable reporter cell lines, the PD-L1Prom-DSRed-FireflyLuciferase/Neo lentiviral construct was cloned as described in Supplemental Experimental Procedures. shRNA lentiviral particles based on the pGIPZ lentiviral vector (Dharmacon) carrying hairpins for the specific genes were generated at UCLA’s Molecular Screening Shared Resource (MSSR) from the shRNA Hannon collection. Plasmids were prepared using the PureLink HiPure Filter Plasmid Maxiprep Kit (Invitrogen) or NucleoSpin 96-well Miniprep kits (Macherey-Nagel), and lentiviral particles were produced as previously described (Kappes and Wu, 2001 (link); Silva et al., 2005 (link)).
+ Open protocol
+ Expand
4

Generating Stable Reporter Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the transient reporter analyses, PD-L1 and PD-L2 promoters were amplified by PCR from genomic DNA obtained from Jurkat cells using the primers listed in Table S1 and cloned into the multicloning site (MCS) of the PGL3 Basic Vector (Promega Corporation) as previously described (Sambrook et al., 1989 ; full methods can be found in Supplemental Experimental Procedures). Specific deletions of the putative binding sites were carried out using the Q5 Site-Directed Mutagenesis Kit (New England Biolabs), with primers and templates listed in Table S1. Normalization pRL-SV40P plasmid (Addgene plasmid 27163) was a gift from Ron Prywes (Chen and Prywes, 1999 (link)), who deposited the plasmid at the Addgene public repository.
For the stable reporter cell lines, the PD-L1Prom-DSRed-FireflyLuciferase/Neo lentiviral construct was cloned as described in Supplemental Experimental Procedures. shRNA lentiviral particles based on the pGIPZ lentiviral vector (Dharmacon) carrying hairpins for the specific genes were generated at UCLA’s Molecular Screening Shared Resource (MSSR) from the shRNA Hannon collection. Plasmids were prepared using the PureLink HiPure Filter Plasmid Maxiprep Kit (Invitrogen) or NucleoSpin 96-well Miniprep kits (Macherey-Nagel), and lentiviral particles were produced as previously described (Kappes and Wu, 2001 (link); Silva et al., 2005 (link)).
+ Open protocol
+ Expand
5

Lentiviral Knockdown of PRDX4 in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pGIPZ lentiviral vector of 11.8 kb size (GE Healthcare Dharmacon Inc., Lafayette, CO, USA) harbors a reporter and a puromycin resistance gene. The encoded reporter gene is translated into a green fluorescent protein (GFP). The lentiviral vector is controlled by the immediate-early cytomegalovirus (CMV) promoter (Fig. 1). HepG2 cells were transduced with three individual shRNA clones against PRDX4 (NM_006406.1): sequence 1 (cat. no. 370039), sequence 2 (cat. no. 370042) and sequence 3 (cat. no. 200074) (GE Healthcare Dharmacon Inc.). Non-targeting negative control shRNA (cat. no. RHS4346), consisting of a random sequence and a positive control GAPDH-shRNA lentivirus (cat. no. RHS4372), were used as a control (GE Healthcare Dharmacon Inc.). The sequences are listed in Table I.
+ Open protocol
+ Expand
6

Rac1 and Rac2 Knockdown in RAW/LR5 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reduction of Rac1 and Rac2 expression in RAW/LR5 cells was achieved by short hairpin RNA directed against their respective mRNA. For Rac1, coding DNA targeting shRNA sequence 5’-agacggagctgttggtaaa-3’ was generated using siDESIGN (GE Dharmacon) and inserted into pSuper.retro.puro retroviral vector (Oligoengine) via BglII and HindIII restriction sites; empty pSuper.retro.puro vector was used as control (shCtrl1). For Rac2, shRNA sequence 5'-caaagggagagatgtggaa-3' (targeting 3’UTR) in pGIPZ lentiviral vector or empty pGIPZ vector (Dharmacon) as control (shCtrl2) were obtained from Einstein shRNA Core Facility. Control and shRNA plasmids were transfected into GP2-293 packaging cell lines (Clontech) using Lipofectamine2000 (Invitrogen) according to manufacturer's instructions. Viral supernatants were concentrated using Retro-X concentrator (Clontech) following the manufacturer's protocol and the concentrated viral stocks were used to infect RAW/LR5 cells. Transduced cells were selected in puromycin, up to 7 μg/mL in gradual increments, to achieve stable genomic integration. Reduction of protein expression was determined by western blotting.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!